PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms

Autor: Yi, Jae-Hyuk, Park, Seung-Won, Brooks, Nathaniel, Lang, Bradley T., Vemuganti, Raghu
Zdroj: In Brain Research 2008 1244:164-172
Databáze: ScienceDirect